Naturhouse Health Statistics
Total Valuation
Naturhouse Health has a market cap or net worth of GBP 87.96 million. The enterprise value is 68.38 million.
Market Cap | 87.96M |
Enterprise Value | 68.38M |
Important Dates
The next estimated earnings date is Friday, February 28, 2025.
Earnings Date | Feb 28, 2025 |
Ex-Dividend Date | Aug 29, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 13.12M |
Valuation Ratios
The trailing PE ratio is 10.65.
PE Ratio | 10.65 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 3.81 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.97, with an EV/FCF ratio of 5.53.
EV / Earnings | 8.28 |
EV / Sales | 1.62 |
EV / EBITDA | 4.97 |
EV / EBIT | 5.67 |
EV / FCF | 5.53 |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.17.
Current Ratio | 2.09 |
Quick Ratio | 1.91 |
Debt / Equity | 0.17 |
Debt / EBITDA | 0.28 |
Debt / FCF | 0.31 |
Interest Coverage | 22.09 |
Financial Efficiency
Return on equity (ROE) is 33.98% and return on invested capital (ROIC) is 25.57%.
Return on Equity (ROE) | 33.98% |
Return on Assets (ROA) | 18.02% |
Return on Capital (ROIC) | 25.57% |
Revenue Per Employee | 214,731 |
Profits Per Employee | 41,930 |
Employee Count | 207 |
Asset Turnover | 1.02 |
Inventory Turnover | 4.97 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.79% in the last 52 weeks. The beta is 0.76, so Naturhouse Health's price volatility has been lower than the market average.
Beta (5Y) | 0.76 |
52-Week Price Change | +7.79% |
50-Day Moving Average | 1.70 |
200-Day Moving Average | 1.70 |
Relative Strength Index (RSI) | 55.73 |
Average Volume (20 Days) | 28 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Naturhouse Health had revenue of GBP 42.30 million and earned 8.26 million in profits. Earnings per share was 0.14.
Revenue | 42.30M |
Gross Profit | 30.28M |
Operating Income | 12.00M |
Pretax Income | 11.53M |
Net Income | 8.26M |
EBITDA | 12.47M |
EBIT | 12.00M |
Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 23.52 million in cash and 3.88 million in debt, giving a net cash position of 19.64 million.
Cash & Cash Equivalents | 23.52M |
Total Debt | 3.88M |
Net Cash | 19.64M |
Net Cash Per Share | n/a |
Equity (Book Value) | 23.40M |
Book Value Per Share | 0.39 |
Working Capital | 15.22M |
Cash Flow
In the last 12 months, operating cash flow was 12.99 million and capital expenditures -618,060, giving a free cash flow of 12.37 million.
Operating Cash Flow | 12.99M |
Capital Expenditures | -618,060 |
Free Cash Flow | 12.37M |
FCF Per Share | n/a |
Margins
Gross margin is 71.58%, with operating and profit margins of 28.38% and 19.53%.
Gross Margin | 71.58% |
Operating Margin | 28.38% |
Pretax Margin | 27.25% |
Profit Margin | 19.53% |
EBITDA Margin | 29.49% |
EBIT Margin | 28.38% |
FCF Margin | 29.25% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 7.92%.
Dividend Per Share | 0.14 |
Dividend Yield | 7.92% |
Dividend Growth (YoY) | 96.46% |
Years of Dividend Growth | 1 |
Payout Ratio | 92.37% |
Buyback Yield | n/a |
Shareholder Yield | 7.92% |
Earnings Yield | 9.39% |
FCF Yield | 14.07% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Naturhouse Health has an Altman Z-Score of 5.17.
Altman Z-Score | 5.17 |
Piotroski F-Score | n/a |